Cargando…
Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod
Multiple sclerosis (MS) is an immune-mediated demyelinating disease that alters central nervous system (CNS) functions. Relapsing-remitting MS (RRMS) is the most common form, which can transform into secondary-progressive MS (SPMS) that is associated with progressive neurodegeneration. Single-nucleu...
Autores principales: | Kihara, Yasuyuki, Zhu, Yunjiao, Jonnalagadda, Deepa, Romanow, William, Palmer, Carter, Siddoway, Benjamin, Rivera, Richard, Dutta, Ranjan, Trapp, Bruce D., Chun, Jerold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247150/ https://www.ncbi.nlm.nih.gov/pubmed/35783097 http://dx.doi.org/10.3389/fncel.2022.918041 |
Ejemplares similares
-
Ponesimod inhibits astrocyte‐mediated neuroinflammation and protects against cingulum demyelination via S1P(1)‐selective modulation
por: Kihara, Yasuyuki, et al.
Publicado: (2022) -
Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
por: Gasperini, Claudio, et al.
Publicado: (2013) -
Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
por: Lorscheider, Johannes, et al.
Publicado: (2020) -
Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
por: Yavari, Fatemeh, et al.
Publicado: (2021) -
S1P(2)-Gα(12) Signaling Controls Astrocytic Glutamate Uptake and Mitochondrial Oxygen Consumption
por: Jonnalagadda, Deepa, et al.
Publicado: (2021)